Bimzelx 320 MG in 2 ML Prefilled Syringe

RxCUI: 2699124
RxNorm name: Bimzelx 320 MG in 2 ML Prefilled Syringe
Display name: Bimzelx 320 MG in 2 ML Prefilled Syringe
Full name: Bimzelx 320 MG in 2 ML Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761151	Bimzelx	bimekizumab-bkzx	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bimzelx	BIMEKIZUMAB	UCB, Inc.	26b88358-871f-4c80-9d80-b2fb16477f81	2025-06-16	Warnings, Adverse reactions	Exact identifier rxcui: 2699124

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
26b88358-871f-4c80-9d80-b2fb16477f81	Bimzelx 320 MG in 2 ML Prefilled Syringe	PSN	14	These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023	20250616
26b88358-871f-4c80-9d80-b2fb16477f81	Bimzelx 320 MG per 2 ML Prefilled Syringe	SY	14	These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023	20250616
26b88358-871f-4c80-9d80-b2fb16477f81	2 ML bimekizumab-bkzx 160 MG/ML Prefilled Syringe [Bimzelx]	SBD	14	These highlights do not include all the information needed to use BIMZELX safely and effectively. See full prescribing information for BIMZELX. BIMZELX® (bimekizumab-bkzx) injection, for subcutaneous use Initial U.S. Approval: 2023	20250616